 Proactive Investors USA & Canada | iBio announces production of biosimilar rituximab drug, shares rally Proactive Investors USA & Canada iBio (AMEX:IBIO) shares rallied around 10% Wednesday after the company announced that its proprietary iBioLaunch technology has been used to produce a functional, monoclonal antibody copy of rituximab, which is used to treat lymphomas, ... iBio Announces Production of Biosimilar Rituximab with its iBioLaunch™ Technology |
